PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1930169-0	1991	Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation.	Podophyllotoxin	42-57	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	14-19	
1930169-4	1991	c-myc mRNA levels decreased biphasically by hemin or podophyllotoxin, while the combined treatment of hemin plus podophyllotoxin did not result in the initial decrease in c-myc mRNA level.	Podophyllotoxin	53-68	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	0-5	
34584548-0	2021	Podofilox suppresses gastric cancer cell proliferation by regulating cell cycle arrest and the c-Myc/ATG10 axis.	Podophyllotoxin	0-9	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	95-100	
34584548-9	2021	Molecular analysis based on microarray data demonstrated that podofilox altered the expression levels of genes involved in the cell cycle, c-Myc and p53 signaling.	Podophyllotoxin	62-71	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	139-144	
34584548-12	2021	Taken together, the results of the present study suggested that podofilox may inhibit GC cell proliferation by preventing the cell cycle progression and regulating the c-Myc/ATG10 signaling pathway.	Podophyllotoxin	64-73	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	168-173	
1317259-0	1992	Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.	Podophyllotoxin	38-57	MYC proto-oncogene, bHLH transcription factor	Homo sapiens	100-105